Teva Named in Patent Lawsuit Over Generic Belbuca Challenge

By Sam | February 6, 2017

Teva Pharmaceuticals has been named in a patent infringement lawsuit as it attempts to develop a generic version of Belbuca, a long-acting opioid painkiller sponsored by BioDelivery Sciences International and Arius Two.
Source: Drug Industry Daily

Posted in Drug Industry Daily